Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.

Jandrasits, Damian; Züst, Roland; Siegrist, Denise; Engler, Olivier B; Weber, Benjamin; Schmidt, Kristina M; Jonsdottir, Hulda R (2024). Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers. Heliyon, 10(10) Elsevier 10.1016/j.heliyon.2024.e31490

[img]
Preview
Text
1-s2.0-S2405844024075212-main.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (2MB) | Preview

Due to the discontinuation of routine smallpox vaccination after its eradication in 1980, a large part of the human population remains naïve against smallpox and other members of the orthopoxvirus genus. As a part of biosafety personnel protection programs, laboratory workers receive prophylactic vaccinations against diverse infectious agents, including smallpox. Here, we studied the levels of cross-protecting neutralizing antibodies as well as total IgG induced by either first- or third-generation smallpox vaccines against Monkeypox virus, using a clinical isolate from the 2022 outbreak. Serum neutralization tests indicated better overall neutralization capacity after vaccination with first-generation smallpox vaccines, compared to an attenuated third-generation vaccine. Results obtained from total IgG ELISA, however, did not show higher induction of orthopoxvirus-specific IgGs in first-generation vaccine recipients. Taken together, our results indicate a lower level of cross-protecting neutralizing antibodies against Monkeypox virus in recipients of third-generation smallpox vaccine compared to first-generation vaccine recipients, although total IgG levels were comparable.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Jonsdottir, Hulda Run

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2405-8440

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

03 Jun 2024 15:28

Last Modified:

04 Jun 2024 03:12

Publisher DOI:

10.1016/j.heliyon.2024.e31490

PubMed ID:

38826712

Uncontrolled Keywords:

ELISA Imvamune/Imvanex/Jynneos Monkeypox virus Neutralizing antibodies Occupational biosafety Vaccines Vaccinia virus serum neutralization test

BORIS DOI:

10.48350/197518

URI:

https://boris.unibe.ch/id/eprint/197518

Actions (login required)

Edit item Edit item
Provide Feedback